|
市場調査レポート
商品コード
1527813
バイオセンサーの世界市場：市場規模、シェア、成長分析 - タイプ別、製品別、技術別、コンポーネント別、用途別、エンドユーザー別、地域別、産業予測、2024～2031年Biosensors Market Size, Share, Growth Analysis, By Type, Product, Technology, Component, Application, End-User, and Region - Industry Forecast 2024-2031 |
||||||
|
|||||||
| バイオセンサーの世界市場：市場規模、シェア、成長分析 - タイプ別、製品別、技術別、コンポーネント別、用途別、エンドユーザー別、地域別、産業予測、2024～2031年 |
|
出版日: 2024年07月22日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のバイオセンサーの市場規模は、2022年に約267億6,000万米ドル、2023年に289億米ドルに達し、2024～2031年の予測期間中にCAGR 8.0%で成長し、2031年には535億9,000万米ドルに達すると予測されています。
バイオセンサー市場は、ナノテクノロジーとバイオテクノロジーの進歩によって急速な成長を遂げています。これらの次世代センサーは、細菌細胞やその他の生体分子を検出する効率と精度を向上させ、ヘルスケア、農業、食品安全などの多様な分野で応用されています。ヘルスケア産業は、グルコースモニタリング、尿路結石検出、薬物濃度追跡などにバイオセンサーを活用しています。また、食品・飲料業界では、バイオセンサーを品質管理と安全性に活用しています。バイオセンサーのスマートウォッチなどのウェアラブルデバイスへの統合は、市場の可能性をさらに広げています。テクノロジーの進化に伴い、バイオセンサーは様々な業界でますます重要な役割を担っていくことでしょう。
目次
イントロダクション
- 調査の目的
- 定義
- 市場範囲
調査手法
- 情報調達
- 二次データソース・一次データソース
- 市場規模予測
- 市場想定と制限
エグゼクティブサマリー
- 市場概要見通し
- 供給需要動向分析
- セグメント別機会分析
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- ポーターの分析
主な市場の考察
- 技術分析
- 価格分析
- 特許分析
- バリューチェーン分析
- 貿易分析
- 市場のエコシステム
- ケーススタディ分析
- 規制情勢
- PESTEL分析
- イノベーションマトリクス
- 主な投資の分析
- 主な成功要因
- 市場魅力度指数
- 競合の程度
バイオセンサー市場：タイプ別
- 市場概要
- センサーパッチ
- 組み込みデバイス
バイオセンサー市場：製品別
- 市場概要
- ウェアラブルバイオセンサー
- リストウェア
- アイウェア
- フットウェア
- ネックウェア
- ボディーウェア
- その他
- ウェアラブルバイオセンサー
バイオセンサー市場：技術別
- 市場概要
- 電気化学バイオセンサー
- アンペロメトリック
- 電位差測定
- 伝導度
- 光学的バイオセンサー
- SPR
- 比色分析
- 蛍光
- 圧電バイオセンサー
- 音響
- マイクロカンチレバー
- サーマルバイオセンサー
- ナノメカニカルバイオセンサー
バイオセンサー市場：コンポーネント別
- 市場概要
- 生体受容体分子
- 生物学的要素
- トランスデューサー
バイオセンサー市場：用途別
- 市場概要
- POC
- 血糖モニタリング
- 心臓マーカー
- 感染症検出
- 凝固モニタリング
- 妊娠検査
- 血液ガス・電解質の検出
- 腫瘍またはがんマーカーの検出
- 尿検査
- コレステロール検査
- 家庭診断
- 血糖モニタリング
- 妊娠検査
- コレステロール検査
- 研究所
- 環境モニタリング
- 食品・飲料
- バイオディフェンス
バイオセンサーの市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- イタリア
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2023年）
- 主な市場企業が採用した戦略
- 市場における最近の活動
- 主要企業の市場シェア（2023年）
主要企業プロファイル
- Abbott Laboratories（US）
- Roche Diagnostics-（Switzerland）
- Johnson & Johnson（US）
- Medtronic（Ireland）
- Siemens Healthcare GmbH（Germany）
- GE Healthcare（US）
- LifeScan, Inc.（US）
- Bio-Rad Laboratories（US）
- Nova Biomedical（US）
- Dexcom（US）
- AgaMatrix, Inc.（US）
- Biosensors International Group, Ltd.（Singapore）
- Sysmex Corporation（Japan）
- F. Hoffmann-La Roche AG（Switzerland）
- PTS Diagnostics（US）
- Acon Laboratories, Inc.（US）
- Medtronic Diabetes（US）
- Universal Biosensors, Inc.（Australia）
- Analog Devices, Inc.（US）
- Lifescan Medical Devices Co., Ltd.（China）
- Biosensing Instrument, Inc.（US）
- Miraculins Inc.（Canada）
- I-SENS, Inc.（South Korea）
- LifeSensors, Inc.（US）
- GlySens Incorporated（US）
Global Biosensors Market size was valued at around USD 26.76 billion in 2022 and is poised to grow from USD 28.9 billion in 2023 to USD 53.59 billion by 2031, at a CAGR of 8.0% over the forecast period (2024-2031).
The biosensor market is experiencing rapid growth driven by advancements in nanotechnology and biotechnology. These next-generation sensors offer enhanced efficiency and accuracy in detecting bacterial cells and other biomolecules, finding applications in diverse sectors like healthcare, agriculture, and food safety. The healthcare industry is a major adopter, utilizing biosensors for glucose monitoring, UTI detection, and drug level tracking. Additionally, the food and beverage industry employs biosensors for quality control and safety. The integration of biosensors into wearable devices, such as smartwatches, is further expanding market potential. As technology continues to evolve, biosensors are poised to play an increasingly critical role in various industries.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biosensors Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Biosensors Market Segmental Analysis
Global Biosensors Market is segmented by type, product, technology, component, application and region. Based on type, the market is segmented into sensor patch, and embedded device. Based on product the market is segmented into wearable biosensors (wristwear, eyewear, footwear, neckwear, bodywear and others) and non-wearable biosensors. Based on technology, the market is segmented into electrochemical biosensors (amperometric, potentiometric and conductometric), optical biosensors (SPR, colorimetric and fluorescence), piezoelectric biosensors (acoustic and microcantilever), thermal biosensors, and nanomechanical biosensors. Based on component, the market is segmented into bioreceptor molecules, biological elements, and transducer. Based on application, the market is segmented into POC (glucose monitoring, cardiac marker, infectious disease detection, coagulation monitoring, pregnancy testing, blood gas & electrolyte detection, detection of tumor or cancer marker, urinalysis testing and cholesterol testing), home diagnosis (glucose monitoring, pregnancy testing and cholesterol testing), research labs, environmental monitoring, food and beverages and biodefense. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Biosensors Market
Nanotechnology has revolutionized biosensors, creating devices with nanoscale materials that enhance biological signal detection and transduction. These sensors, often integrated with electrical systems, utilize nanomaterials like nanotubes, nanowires, and nanoparticles to detect various biomolecules. Applications span from glucose monitoring to fluorescence-based detection and biomolecular analysis, demonstrating the versatility of nanotechnology in biosensing.
Restraints in the Global Biosensors Market
The biosensor market faces significant challenges hindering widespread adoption. High production costs and limited demand outside healthcare have slowed the commercialization of this promising technology. Expanding biosensor applications into areas like biodefense, military, and environmental monitoring is hampered by insufficient research and development. Additionally, consumer acceptance, price sensitivity, and concerns about product reliability further impede market growth.
Market Trends of the Global Biosensors Market
Wearable biosensors are driving significant growth in the biosensor market. These small, non-invasive devices, often integrated into smartwatches and fitness trackers, monitor various health parameters like heart rate, blood glucose, and sleep patterns. Advancements in sensor technology have made them smaller, more efficient, and suitable for continuous wear. The increasing prevalence of chronic diseases, coupled with the rise of digital health and remote patient monitoring, is fueling demand. As wearable biosensors become more accessible and affordable, they are poised to revolutionize healthcare by providing individuals with valuable insights into their health and enabling proactive management of chronic conditions.
Table of Contents
Introduction
- Objectives of the Study
- Definitions
- Market Scope
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Market Overview Outlook
- Supply Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Patent Analysis
- Value Chain Analysis
- Trade Analysis
- Ecosystem of the Market
- Case Study Analysis
- Regulatory Landscape
- PESTEL Analysis
- Innovation Matrix
- Top Investment Analysis
- Key Success Factor
- Market Attractive Index
- Degree of Competition
Biosensors Market by Type
- Market Overview
- Sensor Patch
- Embedded Devices
Biosensors Market by Product
- Market Overview
- Wearable Biosensors
- Wristwear
- Eyewear
- Footwear
- Neckwear
- Bodywear
- Others
- Wearable Biosensors
Biosensors Market by Technology
- Market Overview
- Electrochemical Biosensors
- Amperometric
- Potentiometric
- Conductometric
- Optical Biosensors
- SPR
- Colorimetric
- Fluorescence
- Piezoelectric Biosensors
- Acoustic
- Microcantilever
- Thermal Biosensors
- Nanomechanical Biosensors
Biosensors Market by Component
- Market Overview
- Bioreceptor Molecules
- Biological Elements
- Transducer
Biosensors Market by Application
- Market Overview
- POC
- Glucose Monitoring
- Cardiac Marker
- Infectious Disease Detection
- Coagulation Monitoring
- Pregnancy Testing
- Blood Gas & Electrolyte Detection
- Detection of Tumor or Cancer Marker
- Urinalysis Testing
- Cholesterol Testing
- Home Diagnosis
- Glucose Monitoring
- Pregnancy Testing
- Cholesterol Testing
- Research Labs
- Environmental Monitoring
- Food and Beverages
- Biodefense
Biosensors Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- Italy
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2023
- Strategies Adopted by Key Market Players
- Recent Activities in the Market
- Key Companies Market Share (%), 2023
Key Company Profiles
- Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Diagnostics -(Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthcare GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LifeScan, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nova Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dexcom (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AgaMatrix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biosensors International Group, Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PTS Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Acon Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic Diabetes (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Universal Biosensors, Inc. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Analog Devices, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lifescan Medical Devices Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biosensing Instrument, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Miraculins Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- I-SENS, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LifeSensors, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlySens Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
